News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,433 Results
Type
Article (1927)
Company Profile (2)
Press Release (67504)
Section
Business (21498)
Career Advice (9)
Deals (4564)
Drug Development (8172)
FDA (1809)
Job Trends (806)
News (37086)
Policy (3565)
Tag
Academia (91)
Alliances (8131)
Alzheimer's disease (118)
Antibody-drug conjugate (ADC) (8)
Approvals (1823)
Artificial intelligence (10)
Bankruptcy (8)
Best Places to Work (586)
Biosimilars (13)
Breast cancer (14)
Cancer (158)
Career advice (9)
Cell therapy (16)
Clinical research (6947)
Collaboration (63)
COVID-19 (183)
C-suite (8)
Data (139)
Diabetes (11)
Diagnostics (592)
Drug discovery (12)
Duchenne muscular dystrophy (7)
Earnings (7518)
Events (6901)
Executive appointments (39)
FDA (1902)
Funding (41)
Gene therapy (14)
GLP-1 (40)
Government (233)
Healthcare (1073)
Infectious disease (187)
Inflammatory bowel disease (14)
Intellectual property (7)
IPO (1617)
Job creations (242)
Job search strategy (9)
Layoffs (6)
Legal (950)
Liver cancer (15)
Lung cancer (26)
Lymphoma (9)
Manufacturing (23)
Medical device (1120)
Medtech (1121)
Mergers & acquisitions (3013)
Metabolic disorders (31)
Neuroscience (150)
NextGen: Class of 2025 (221)
Non-profit (61)
Northern California (111)
Obesity (13)
Ovarian cancer (7)
Pancreatic cancer (6)
Parkinson's disease (12)
Patents (12)
People (4939)
Phase I (1887)
Phase II (2902)
Phase III (2643)
Pipeline (60)
Postmarket research (241)
Preclinical (653)
Radiopharmaceuticals (22)
Rare diseases (21)
Real estate (600)
Regulatory (2547)
Research institute (91)
Schizophrenia (6)
Series A (11)
Southern California (102)
Startups (422)
United States (957)
Vaccines (19)
Date
Today (8)
Last 7 days (52)
Last 30 days (202)
Last 365 days (3213)
2025 (202)
2024 (3267)
2023 (3822)
2022 (7020)
2021 (6389)
2020 (5878)
2019 (3875)
2018 (3011)
2017 (3568)
2016 (3177)
2015 (4046)
2014 (3031)
2013 (2602)
2012 (2779)
2011 (2914)
2010 (2666)
Location
Africa (79)
Arizona (7)
Asia (21245)
Australia (2469)
California (249)
Canada (188)
China (119)
Connecticut (11)
Europe (12329)
Florida (15)
Illinois (15)
India (7)
Japan (52)
Maryland (66)
Massachusetts (174)
Minnesota (24)
New Jersey (133)
New York (112)
North Carolina (50)
Northern California (111)
Pennsylvania (35)
South America (107)
Southern California (102)
Texas (17)
Utah (8)
Virginia (14)
69,433 Results for "speedx pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SpeeDx Appoints Jeremy Stackawitz as Chief Executive Officer to Drive Global Expansion of Its Molecular Diagnostics Solutions
October 24, 2024
·
2 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Business
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision
Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced the appointment of Mark W. Womack as a Director of the Board.
March 5, 2024
·
3 min read
Drug Development
SpeeDx Expand COVID-19 Diagnostics to Include Self-Collected Samples
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have added saliva to the list of validated samples for their PlexPCR® SARS-CoV-2 qPCR diagnostic for COVID-19 sales across Europe#.
April 21, 2022
·
3 min read
CARTHERICS GRANTED EUROPEAN PATENT FOR MULTIPLE DEVELOPMENT CANDIDATES
Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer
May 23, 2024
·
2 min read
BioCapital
Eilean Therapeutics Joins The Leukemia & Lymphoma Society’s Groundbreaking Beat AML® Master Clinical Trial
Eilean Therapeutics AU Pty Ltd has joined The Leukemia & Lymphoma Society in the groundbreaking collaborative Beat AML® Master Clinical Trial.
June 11, 2024
·
4 min read
CARTHERICS SECURES AUSTRALIAN PATENT FOR INNOVATIVE CANCER CELL THERAPY
Melbourne, Australia, 12 June 2024 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce...
June 12, 2024
·
2 min read
Policy
SpeeDx Receives Clearance for COVID-19 Diagnostic Test
SpeeDx Pty. Ltd. announced their PlexPCR® SARS-CoV-2* test received clearance from the Australian Therapeutic Goods Administration.
August 11, 2021
·
4 min read
Business
Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that its Australian subsidiary, Psyence Australia Pty Ltd. (“Psyence Australia”), has entered into a partnership with Fluence, a global leader in professional education and training for psychedelic therapy research, and iNGENū CRO Pty Ltd (“iNGENū”), an Australian clinical research organization (CRO), to support an upcoming Phase llb clinical trial.
April 8, 2024
·
8 min read
SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific.
June 30, 2021
·
4 min read
1 of 6,944
Next
